Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 12-2020 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -23,840 | -165,367 | -102,456 | -3,410 |
| Depreciation Amortization | 486 | 1,283 | 339 | 43 |
| Income taxes - deferred | -532 | N/A | -1,867 | N/A |
| Accounts payable and accrued liabilities | 1,047 | N/A | 1,105 | N/A |
| Other Working Capital | -34,290 | 31,176 | -385 | 164 |
| Other Operating Activity | 6,336 | 98,826 | 82,369 | -2,341 |
| Operating Cash Flow | $-50,793 | $-34,082 | $-20,895 | $-5,544 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 32,500 | N/A | -81,841 | N/A |
| PPE Investments | -1,688 | -4,150 | -3,768 | -639 |
| Other Investing Activity | 81 | -69,476 | -171 | -423 |
| Investing Cash Flow | $30,893 | $-73,626 | $-85,780 | $-1,062 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | -1,272 | 269,278 | 270,364 | 34,934 |
| Financing Cash Flow | $-1,272 | $269,278 | $270,364 | $34,934 |
| Beginning Cash Position | 198,545 | 36,975 | 36,975 | 8,647 |
| End Cash Position | 177,373 | 198,545 | 200,664 | 36,975 |
| Net Cash Flow | $-21,172 | $161,570 | $163,689 | $28,328 |
| Free Cash Flow | ||||
| Operating Cash Flow | -50,793 | -34,082 | -20,895 | -5,544 |
| Capital Expenditure | -1,688 | N/A | -3,768 | N/A |
| Free Cash Flow | -52,481 | -34,082 | -24,663 | -5,544 |